IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Gelteq Limited (GELS)

CUSIP: Q3978B109 | Healthcare · Drug Manufacturers - Specialty & Generic | Micro Cap | 13 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2026

Wedbush Securities Inc20,000
0.0% of portfolio›$11
Private Advisor Group, LLC16,531
0.0% of portfolio›$8.8K
UBS Group AG47
0.0% of portfolio›$25
StyleTurnoverLocationFiled
Wedbush Securities Inc
20,000$110.0%CoreLowPasadena, CA2026-10-22
Private Advisor Group, LLC
16,531$8.8K0.0%ETFMediumMorristown, NJ2026-11-10
UBS Group AG
47$250.0%CoreMediumZurich, Switzerland2026-11-10